237 related articles for article (PubMed ID: 16628961)
21. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of pain in rheumatic diseases].
Luttosch F; Baerwald C
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1598-600. PubMed ID: 21809251
[No Abstract] [Full Text] [Related]
23. Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?
Pruthi RS; Kouba E; Carson CC; Wallen EM
Urology; 2006 Nov; 68(5):917-23. PubMed ID: 17113880
[No Abstract] [Full Text] [Related]
24. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
Bijlsma JW; Lems WF; van de Laar MA
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):795-8. PubMed ID: 17469317
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone.
Rainsford KD
Rheumatology (Oxford); 2010 May; 49(5):834-6. PubMed ID: 20097907
[No Abstract] [Full Text] [Related]
26. COX-2 inhibitors and the heart: putting risk in perspective.
Bobadilla RV; Barnett EM; Randels CL
Adv Nurse Pract; 2005 Nov; 13(11):48-50. PubMed ID: 16295003
[No Abstract] [Full Text] [Related]
27. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
[TBL] [Abstract][Full Text] [Related]
28. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
[No Abstract] [Full Text] [Related]
29. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Hermann M; Ruschitzka F
Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
[TBL] [Abstract][Full Text] [Related]
30. Safety of cox-2 selective nonsteroidal antiinflammatory drugs for postsurgical pain.
Babul N; Sloan P; Lipman AG
Anesth Analg; 2006 Feb; 102(2):645-6; author reply 646. PubMed ID: 16428581
[No Abstract] [Full Text] [Related]
31. The unexpected side effects of new nonsteroidal anti-inflammatory drugs.
Uzan A
Expert Opin Emerg Drugs; 2005 Nov; 10(4):687-8. PubMed ID: 16262557
[TBL] [Abstract][Full Text] [Related]
32. NSAIDs and cardiovascular disease.
Patrignani P; Capone ML; Tacconelli S
Heart; 2008 Apr; 94(4):395-7. PubMed ID: 18347364
[No Abstract] [Full Text] [Related]
33. The practice implications of cardiovascular risks in NSAIDs.
Hainsworth T
Nurs Times; 2005 Jun 28-Jul 4; 101(26):26-7. PubMed ID: 16010838
[TBL] [Abstract][Full Text] [Related]
34. [Coxibes--bullying of a drug class?].
Müller P; Simon B
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():63-4. PubMed ID: 18712125
[No Abstract] [Full Text] [Related]
35. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal anti-inflammatory drugs: are they safe after joint arthroplasty for early pain?
Purtill JJ
Instr Course Lect; 2007; 56():133-7. PubMed ID: 17472301
[TBL] [Abstract][Full Text] [Related]
37. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
Boers M
Arthritis Rheum; 2007 Jan; 56(1):384; author reply 384. PubMed ID: 17195242
[No Abstract] [Full Text] [Related]
38. [New epidemiologic data show: conventional NSAIDs need individual benefit-risk evaluation].
MMW Fortschr Med; 2005 Nov; 147(47):62-3. PubMed ID: 16370198
[No Abstract] [Full Text] [Related]
39. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
Weber AA; Hohlfeld T; Harder S
Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
[TBL] [Abstract][Full Text] [Related]
40. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
Aneja A; Farkouh ME
Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
